BioSpace News Archive

Vigeo Therapeutics, a clinical-stage biopharmaceutical company developing novel therapeutics to reprogram the tumor immune microenvironment (TIME), today announced that data from its Phase 1 study evaluating VT1021 in patients with advanced solid tumors will be presented at a poster session at the European Society for Medical Oncology (ESMO) 2019 Congress, September 27-October 1

Carrum Health, the next-generation Center of Excellence (COE) platform for self-insured employers, today announced it has hired two seasoned executives with deep healthcare IT experience and a talent for growing companies.

Access Vascular, a medical device company developing the next generation of intravenous devices from novel biomaterials designed to minimize the risk of bloodstream infection, catheter thrombosis, and vein trauma, announced $6M in new funding from new and existing investors.

The nonsurgical alternative to a surgical facelift is raising awareness about the importance of elastin for skin’s resilience to “snap back” into place

Many Americans want technology – such as artificial intelligence – to help make health care decisions, and a record number say they have used the internet and mobile apps to comparison shop for care, according to a new UnitedHealthcare survey.

ResMed (NYSE: RMD, ASX: RMD) today announced that CEO Mick Farrell will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Monday, September 30, 2019 at 9:30 a.m. ET.

Samsung Hera I10 Transforms Ultrasound with First-of-a-Kind Integrated Ultrasound-Exam Chair Design

The CMA has consistently advocated for an enhanced federal role in health care to address national issues, including addressing access issues for seniors, mental health and hard to reach populations.

Oncopeptides has previously communicated a target enrollment of 150 patients in the study before the end of September, which now has been achieved.

GrowFL is pleased to announce BioDerm as one of this year’s 50 Florida Companies to Watch (#FLCTW) honorees, a statewide competition that identifies companies expected to see significant growth over the next several years.